imatinib

Colombia's Battle With a Cancer Drug Company Could Set a Global Precedent for Generic Meds

Colombia has issued an ultimatum to Swiss pharmaceutical giant Novartis to lower the price of leukemia medication imatinib by the end of the month, or lose its monopoly of the Colombian market.